Literature DB >> 26220819

Planned foveal detachment technique for the resolution of diffuse diabetic macular edema.

Yuki Morizane1, Shuhei Kimura1, Mio Hosokawa1, Yusuke Shiode1, Masayuki Hirano1, Shinichiro Doi1, Mika Hosogi1, Atsushi Fujiwara1, Yasushi Inoue2, Fumio Shiraga3.   

Abstract

PURPOSE: To evaluate the therapeutic efficacy of a novel surgical procedure for diffuse diabetic macular edema (DME), performed in conjunction with conventional vitrectomy.
METHODS: This prospective, interventional case series involved 20 eyes of 18 consecutive DME patients with best-corrected visual acuities (BCVAs) between 0.301 and 1.221 logarithm of the minimal angle of resolution (logMAR) units and central retinal thicknesses (CRTs) greater than 275 μm. After vitrectomy, a small retinal detachment was made in the macula by injecting 50-100 μl balanced salt solution into the subretinal space using a 38-gauge needle. Before finishing the surgery, fluid-air exchange was performed. Patients were asked to remain in prone position for 1 day postoperatively. The main outcome measures were CRT and BCVA.
RESULTS: The mean CRT of 554.6 ± 152.7 μm before surgery significantly decreased to 295.6 ± 92.5 μm (p < 0.0001) 1 week after surgery and to 185.8 ± 67.4 μm (p < 0.0001) at 6 months after surgery. The CRT was less than 250 μm in 18 eyes (90 %) at 6 months after surgery. The mean BCVA before surgery (0.706 ± 0.348) significantly improved at 6 months after surgery (0.431 ± 0.392, p < 0.0001). Postoperative BCVAs improved by more than 0.3 logMAR units in 13 eyes (65 %), remained unchanged in six eyes (30 %) and worsened in one eye (5 %). Macular edema recurred in three eyes (15 %) 2 months after surgery.
CONCLUSIONS: This novel planned foveal detachment technique facilitated a rapid resolution of DME and contributed to improved visual acuity.

Entities:  

Keywords:  Diffuse diabetic macular edema; Foveal detachment; Vitrectomy

Mesh:

Substances:

Year:  2015        PMID: 26220819     DOI: 10.1007/s10384-015-0390-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  34 in total

1.  Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Authors:  D J Pieramici; E De Juan; G Y Fujii; S M Reynolds; M Melia; M S Humayun; A P Schachat; C D Hartranft
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Selection for inferior limited macular translocation on the basis of distance from the fovea to the inferior edge of the subfoveal choroidal neovascularization.

Authors:  Yuki Morizane; Fumio Shiraga; Ippei Takasu; Shinya Yumiyama; Toshio Okanouchi; Hiroshi Ohtsuki
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

3.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.

Authors:  Pascale Massin; Graham Duguid; Ali Erginay; Belkacem Haouchine; Alain Gaudric
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

Review 4.  Ocular oxygenation and the treatment of diabetic retinopathy.

Authors:  Einar Stefánsson
Journal:  Surv Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 6.048

5.  The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

Authors:  E Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2001-10

6.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

7.  Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

8.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Authors:  J W Harbour; W E Smiddy; H W Flynn; P E Rubsamen
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

9.  Transcorneal oxygenation of the preretinal vitreous.

Authors:  C A Wilson; J D Benner; B A Berkowitz; C B Chapman; R M Peshock
Journal:  Arch Ophthalmol       Date:  1994-06

10.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.

Authors:  Robert E MacLaren; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Len Seymour; K Reed Clark; Matthew J During; Frans P M Cremers; Graeme C M Black; Andrew J Lotery; Susan M Downes; Andrew R Webster; Miguel C Seabra
Journal:  Lancet       Date:  2014-01-16       Impact factor: 79.321

View more
  7 in total

1.  Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients.

Authors:  Kazuyuki Kumagai; Nobuchika Ogino; Marie Fukami; Mariko Furukawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-05-25       Impact factor: 3.117

2.  Vitrectomy with ILM peeling in diabetic macular edema in one eye vs. intravitreal anti-VEGF injections in the second eye: a comparative study.

Authors:  Zofia Anna Nawrocka; Zofia Nawrocka; Jerzy Nawrocki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-23       Impact factor: 3.535

Review 3.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

4.  Evaluation of Vitrectomy with Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema with or without Vitreomacular Interface Abnormality.

Authors:  Ahmed M Abdel Hadi
Journal:  J Ophthalmol       Date:  2018-05-07       Impact factor: 1.909

5.  Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema.

Authors:  Samir M El-Baha; Ahmed M Abdel Hadi; Mahmoud A Abouhussein
Journal:  J Ophthalmol       Date:  2019-10-21       Impact factor: 1.909

6.  Six-month postoperative outcomes of intraoperative OCT-guided surgical cystotomy for refractory cystoid macular edema in diabetic eyes.

Authors:  Yuichi Asahina; Naoko Tachi; Yumi Asahina; Kayoko Yoshimura; Yoshiki Ueta; Yoshihiro Hashimoto
Journal:  Clin Ophthalmol       Date:  2017-11-23

7.  The influence of subretinal injection pressure on the microstructure of the monkey retina.

Authors:  Kosuke Takahashi; Yuki Morizane; Toshio Hisatomi; Takashi Tachibana; Shuhei Kimura; Mio Morizane Hosokawa; Yusuke Shiode; Masayuki Hirano; Shinichiro Doi; Shinji Toshima; Ryoichi Araki; Hiroshi Matsumae; Yuki Kanzaki; Mika Hosogi; Atsushi Yoshida; Koh-Hei Sonoda; Fumio Shiraga
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.